ABSTRACT-The fura-2 microscopic fluorimetric method was used to examine the effects of the thromboxane A2 analogue, U46619, on the force of contraction and intracellular calcium concentrations ([Ca 2+]i) in canine coronary arteries. Upon cumulative application, U46619 increased [Ca 2+]; and force. Depolarization by 20 mM KCl potentiated the increase in [Ca 2+]; and increased the maximum force induced by U46619. In 5 mM KCl-PSS, the reduction of resting [Ca 2+]; by cromakalim (3 X 10-6 M) was greater than that by verapamil (3 X 10-6 M). Cromakalim and verapamil inhibited the in creases in [Ca 2+]; and force induced by U46619 in 5 mM KCl-PSS. In 90 mM KCl-PSS in the presence of U46619, verapamil inhibited the increases in [Ca 2+]; and force, whereas cromakalim did not inhibit them at all. The inhibitory effect of cromakalim was counteracted by depolarization by 20 or 25 mM KCI. Curves in the presence of U46619 which related force to [Ca 2+]i were shifted to the left compared with that in the absence of U46619, suggesting that U46619 increases the Ca2+-sensitivity of the con tractile proteins. Thus, U46619 produces Ca 2+ influx through L-type Ca 2+ channels, which are deacti vated by hyperpolarization induced by cromakalim. Thromboxane A2 is a strong vasoconstrictor as well as a potent inducer of platelet aggregation, which is thought to be involved in ischemic states such as angina pectoris and myocardial infarction (1, 2). In canine coronary arteries, carbocyclic thromboxane A2 pro duces a relatively consistent contraction (3). Its mechanism of action is thought to be related with the release of Ca2+ from intracellular storage sites and the Ca 2+ influx (3). However, the methods used were mainly the measurement of force of contraction. Since the signal transduction after the stimulation of various receptors by agonists involves several mechanisms to induce contractions in vascular smooth muscle (4), the simultaneous measurement of force and intracellular Ca 2+ concentrations ([Ca 2+]i) is very crucial. We have studied mostly KCl-induced contractions with various vasodilators, including K+ channel openers, by measuring simultaneously force and [Ca 2+]i using a fura-2 microscopic fluorimetric method (5-7). Recent ly, it has become well-known that the contractions in duced by agonists are inhibited effectively by the K+ channel opener cromakalim (8, 9), the relaxant action of which is generally understood to be due to the in direct closure of L-type Ca2+-channels by its hyper polarizing action on the cell membrane of vascular smooth muscle. However, the effects of K+ channel openers on [Ca 2+]; and force of contraction induced by thromboxane A2 analogues in coronary artery are little investigated. Thus, we wanted to elucidate the mecha nisms and characteristics of vasoconstriction induced by U46619 and examine the relaxation produced by the K+ channel opener cromakalim by measuring [Ca 2+]i and force in canine coronary arteries.
Thromboxane A2 is a strong vasoconstrictor as well as a potent inducer of platelet aggregation, which is thought to be involved in ischemic states such as angina pectoris and myocardial infarction (1, 2) . In canine coronary arteries, carbocyclic thromboxane A2 pro duces a relatively consistent contraction (3) . Its mechanism of action is thought to be related with the release of Ca2+ from intracellular storage sites and the Ca 2+ influx (3) . However, the methods used were mainly the measurement of force of contraction. Since the signal transduction after the stimulation of various receptors by agonists involves several mechanisms to induce contractions in vascular smooth muscle (4) , the simultaneous measurement of force and intracellular Ca 2+ concentrations ([Ca 2+]i) is very crucial. We have studied mostly KCl-induced contractions with various vasodilators, including K+ channel openers, by measuring simultaneously force and [Ca 2+]i using a fura-2 microscopic fluorimetric method (5) (6) (7) . Recent ly, it has become well-known that the contractions in duced by agonists are inhibited effectively by the K+ channel opener cromakalim (8, 9) , the relaxant action of which is generally understood to be due to the in direct closure of L-type Ca2+-channels by its hyper polarizing action on the cell membrane of vascular smooth muscle. However, the effects of K+ channel openers on [Ca 2+]; and force of contraction induced by thromboxane A2 analogues in coronary artery are little investigated. Thus, we wanted to elucidate the mecha nisms and characteristics of vasoconstriction induced by U46619 and examine the relaxation produced by the K+ channel opener cromakalim by measuring [Ca 2+]i and force in canine coronary arteries.
MATERIALS AND METHODS

Preparation of arterial rings
Hearts were obtained from mongrel dogs of either sex, weighing 6 to 15 kg, anesthetized with sodium pentobarbital (30 mg/kg, i.v.). Coronary arterial rings (0.6 1.2 mm in diameter, about 1 mm in width) were dissected, and connective tissues were carefully re moved in a dissecting chamber under a binocular microscope (SZ, Olympus, Tokyo, Japan). The en dothelium was removed by gentle rubbing, and the luminal side was turned to face outwards.
Fluorescence measurements
We performed fluorescence measurements as pre viously described (5) . In brief, coronary arterial rings were exposed to 10 ,u M fura-2 acetoxymethyl ester (fura-2 AM) for about 2 hr at 37°C. The noncytotoxic detergent pluronic F-127 (0.1% W/V) was premixed in the loading physiological salt solution (PSS) to help dissolve the fura-2 AM in PSS. After the fura-2 load ing, muscles were rinsed with normal PSS for longer than 1 hr and then used for the experiments. Fluores cence was measured in a fluorimeter equipped with a dual wavelength excitation device (CAM-200 or CAM 220, Japan Spectroscopic, Tokyo, Japan) connected to an inverted microscope (TMD-8, Nikon, Tokyo, Japan). The fluorescence image was obtained by focus ing on the smooth muscle cells in the medial layer with a Nikon CF UV (Fluor) 10 X objective lens. The mus cle ring was placed horizontally in a temperature-con trolled 0.4 ml tissue bath which was mounted on the in verted microscope and perfused with PSS at a rate of 4 ml/min. The muscle ring was stretched to a resting ten sion of about 5 mN between two tungsten needles, one of which was glued to a transducer element (AE801, AME, Horten, Norway or U-10230, Shinko, Tokyo, Japan). The photosignals and the mechanical activity were measured simultaneously and both were recorded on a chart recorder (Recti-horiz-8K, NEC-San-ei, Tokyo, Japan). They were also digitized by A/D con verters and fed into a microcomputer (PC-9801, NEC, Tokyo, Japan) for further calculation and graphical analysis (10) . Every experiment commenced with perfusion with 90 mM KCl-PSS for 10 min. At the end of each experiment, the cell membrane was lysed with the detergent Triton X-100 (1%), and autofluorescence signals were determined by quenching fura-2 signals with MnC12. We subtracted the F340 and F380 values due to autofluorescence from the corresponding values of F34o and F380 obtained under conditions of fura-2 loading to derive a recalculated ration. Since it is diffi cult to calculate the absolute concentration of [Ca 2+]i (11, 12) , we used the relative F34o/F380 ratio as an in dicator of [Ca 2+]i (5, 13) . Changes in the ratiorc (changes in [Ca 2+];) and those in force were expressed as percentages of the differences between basal values and those obtained with a 10-min perfusion with 90 mM KCl-PSS. None of the drugs and chemicals used in the present study, with the exception of fura-2 and MnC12, affected the fluorescence signals at the concen trations used.
Protocol
Preparations were exposed to cumulative concentra tions of U46619 (10-9 to 3 X 10-7 M) every 5 min, fol lowing washout with the drug-free 5 mM KCI-PSS for 30 min. The perfusion with 20 mM KCI-PSS or drug containing PSS was followed by the cumulative applica tion of U46619 every 5 min. In the experiments with cromakalim (3 X 10-6 M) and verapamil (3 X 10-6 M), at the end of exposure to cumulative concentra tions of U46619 (10_8 to 3 X 10-7 M), the rings were perfused with 90 mM KC1 containing U46619 (3 X 10-7 M) for 10 min.
Drugs and solutions
The composition of normal or 5 mM KCI physiolo gical salt solution (PSS) was as follows: 140 mM NaCl, 5 mM KCI, 2.5 mM CaCl2, 2.5 mM MgC12, 11.1 MM glucose, 3 mM HEPES (pH 7.4). The solution was equilibrated with 100%02 at 37°C. High KCl-PSS was made by substituting NaCI with equimolar KCI. Cat+ free PSS was made by removing CaC12 from normal PSS and by adding 1 mM EGTA to the solution. Drugs and chemicals were obtained from the follow ing sources: cromakalim (Beecham, Harlow, U.K.), verapamil hydrochloride (Eisai, Tokyo, Japan), U46619 (9,11-dideoxy-11a,9a-epoxymethano-prostaglan din F2a; Sigma, St. Louis, MO, U.S.A.), EGTA (glycol etherdiamine-tetraacetic acid), HEPES (N-2-hydroxy ethyl-piperazine-N'-2-ethanesulphonic acid), fura-2 AM and pluronic F-127 (Dojin, Kumamoto, Japan), DMSO (dimethyl sulphoxide) and Triton X-100 (Wako, Tokyo, Japan). U46619 was dissolved in ethanol to a concentration of 1 mM. Cromakalim was dissolved in 70% ethanol to a concentration of 10 mM. Fura-2 AM was dissolved in DMSO at the concentration of 1 mM. Pluronic F-127 was dissolved in 25% w/v in DMSO. Triton X-100 was dissolved in 1% w/v in PSS. Other drugs or chemicals were dissolved in distilled water and diluted to the desired concentrations by PSS.
Analysis of concentration-response curves for U46619 and statistical analysis
To examine the potencies of U46619 and the max imum responses produced by U46619 in 5 mM KCl PSS and in 20 mM KCI-PSS, the concentration-re sponse curves for U46619 in increasing [Ca2+]; and force of contraction were computer-fitted to the equa tion (1) .
where E is the effect normalized by the differences be tween basal values and those of 90 mM KCI at 10 min, M is the maximum responses, A is the concentration of U46619, K is the EC50 value of U46619 and p is the slope parameter. EC50 values were presented as pD2 (pD2 = log EC50) Experimental values are given as means ± S.E.M. Statistical significance of results was evaluated by Stu dent's t-test. A P value smaller than 0.05 was consi dered to indicate a significant difference. (Fig. 1, a and b) . The summarized data obtained from analysis of concentration-response curves for U46619 to increase [Ca 2+]i and force are presented in Table 1 . In 20 mM KCl-PSS, the pD2 value of U46619 to increase [Ca 2+]i was increased, whereas that to increase force was not changed. The maximum effect of U46619 to increase the force of contraction was increased; how ever, that to increase [Ca2+]i was not changed. Thus, in 20 mM KCI-PSS, the pD2 values of U46619 to in crease [Ca2+]i and force became different (P < 0.05).
We examined the influences of U46619 (10- (5 mM), the force was much larger in the presence of U46619 than in its absence (Fig. 1c) . After exposure to cumulative concentrations of U46619 (10-8 to 3 X 10-7 M), the preparation was de polarized by 90 mM KCl-PSS in the presence of 3 X 10-7 M U46619. The increase in [Ca 2+]i produced by 90 mM KCl-PSS was almost the same as that in the absence of U46619, whereas the force of contraction was almost twice that in its absence (Fig. 2, a and b) . After washout with 5 mM KCl-PSS for 30 min, croma kalim (3 X 10-6 M) was administered. As in a pre vious study (6) , cromakalim reduced the basal [Ca 2+]i without changing the force. Cromakalim almost abo lished the increases in [Ca 2+]i and force induced by U46619 (Fig. 2a) . In the presence of cromakalim, 90 mM KCl-PSS containing U46619 at 3 X 10-7 M which had been reached cumulatively produced increases in [Ca 2+]i and force comparable to those in the absence of cromakalim (Fig. 2a, Table 2 ).
In the presence of verapamil (3 X 106 M), [Ca 2+]i became slightly lower than the basal level. The de crease in [Ca 2+], produced by verapamil was smaller than that by cromakalim. Verapamil greatly reduced the increases in [Ca 2+]i and force induced by U46619 (Fig. 2b) . In the presence of verapamil, 90 mM KCI PSS containing U46619 (3 X 10-7 M) produced in creases in [Ca 2+]i and force which were significantly smaller than those in the absence of verapamil (P < 0.01, Table 2 ). The summarized data concerning the effects of cromakalim and verapamil and their influ ences on the concentration-response relations of U46619 are shown in Fig. 2, c and d .
Modification by depolarization of the inhibitory effects of cromakalim on changes in [Ca2+], an force induced by U46619
Because, as described in the previous section, the application of 90 mM KCl abolished the inhibitory effects of cromakalim (3 X 10-6 M) on U46619 in duced changes in [Ca 2+]i and force, we wanted to de termine the concentration of KCl and the extent of de polarization to counteract the hyperpolarization in duced by cromakalim. Figure 3a force are shown in Fig. 3, b and c. The concentration response curve for U46619 in the presence of cromaka lim in 20 mM KCl-PSS was located below the control curve and that in its presence in 25 mM KCl-PSS was located above the control curve. Therefore, the opti mal concentration of KCl in PSS which counteracts both the hyperpolarizing action and the inhibitory effects of cromakalim (3 X 10-6 M) on changes in [Ca 2+]i and force induced by U46619 is between 20 and 25 mM. 
DISCUSSION
The present study demonstrated the following re sults: In canine coronary arteries, U46619 administered cumulatively produces an increase in [Ca 2+]i due to Ca 2+ influx. The Ca 2+ influx induced by U46619 is enhanced by depolarization and abolished by the Ca 2+ channel blocker verapamil. The Ca 2+ infulx caused by U46619 is also inhibited by the K+ channel opener cromakalim, which is counteracted by the depolariza tion produced by an increase in KCI concentration. U46619 increases the Ca 2+-sensitivity of the contractile proteins.
Thromboxane A2 is a potent constrictor of vascular smooth muscle as well as a strong inducer of platelet aggregation (14) (15) (16) . U46619 is a stable and full ago nist analogue of thromboxane A2 (17, 18) . Recently, the human thromboxane A2 receptor was cloned, and its amino-acid sequence shows that it is one of the G protein coupled receptors (19) . The vasoconstrictor mechanisms of thromboxane A2 analogues have been proposed to involve their ability to cause Ca 2+ release from intracellular stores and increase transmembrane Ca 2+ influx (3, 20) . However, the cumulative manner of the application of U46619 (10_9-3 X 10-7 M) seems not to induce a marked release of Ca 2+ in this study. The application of U46619 at a higher concen tration (3 X 10-7 M) at once induced a Ca 2+ release in the absence of extracellular Ca 2+ (data not shown). In the present study, the increase in [Ca 2+1i induced by U46619 was potentiated by depolarization by 20 mM KCI, and the curve which related [Ca 2+]i to extracellu lar KCl concentrations was shifted to the left by U46619 (Fig. 1) . Verapamil inhibited the increases in [Ca 2+]i and force caused by the cumulative applica tions of U46619 (Fig. 2) . In our previous study (21) , Ca 2+ influx induced by histamine was also abolished by verapamil. These results suggest that the Ca 2+ in flux induced by agonists including U46619 is verapamil sensitive and associated with that through voltage-de pendent L-type Ca 2+ channels (4) .
The inhibitory effect of cromakalim on changes in [Ca 2+]i and force induced by U46619 was counteracted by increasing KCl concentration in PSS (Figs. 2 and 3) . The optimal concentration of KCl was between 20 and 25 mM. An increase in KCl concentration is known to increase the K+ conductance of the plasma membrane (22) . Thus, the counteracting influence of the increase in KCI concentration seems to be mainly due to its membrane depolarization effect. Therefore, the inhibi tory action of cromakalim on Ca2+ influx seems to be due to deactivation of L-type Ca 2+ channels by hyper polarization of the plasma membrane as is the case with the KCl-depolarization-induced Ca 2+ influx (6) . The same inhibitory mechanisms of cromakalim were reported in the noradrenaline-induced contraction of rabbit aorta (23, 24) .
The increase in the Ca 2+ sensitivity of contractile proteins by various agonists has been reported in pig coronary artery (21) , rabbit pulmonary artery (25) and rat aorta (13) . The relationship between [Ca 2+]i and force shows that U46619 has an action to increase the Ca 2+-sensitivity of contractile proteins (Fig. 4) . In the simultaneous application of 90 mM KCl with U46619 at 3 X 10-7 M, the increase in [Ca 2+]i and force were not changed by cromakalim, whereas verapamil greatly re duced the increases in both [Ca 2+]i and force induced by 90 mM KCl without changing the relationship be tween [Ca 2+]i and force (Fig. 4) . Since the relation ships between [Ca 2+]i and force are not changed by cromakalim and verapamil, they do not change the in creased Ca 2+ sensitivity of contractile proteins by U46619 in 90 mM KCl-PSS (Fig. 2, b and d) . One possible mechanism of Ca2+-sensitizing is the activa tion of protein kinase C (26, 27) mediated by the formation of diacylglycerol after the agonist activation of phospholipase C (13, 21, 28) or phospholipase D (29) .
In summary, U46619 produces Ca 2+ influx through L-type channels, which are deactivated by hyperpolar ization induced by cromakalim in canine coronary artery.
